Corticosteroid after etomidate in critically ill Patients: A randomized controlled Trial

Critical Care Medicine

Volumn 40, Issue 1, 2012, Pages 29-35

  Payen, Jean Francois ^a,b   Dupuis, Clément ^a   Trouve Buisson, Thibaut ^a   Vinclair, Marc ^a   Broux, Christophe ^a   Bouzat, Pierre ^a,b   Genty, Céline ^c   Monneret, Denis ^d   Faure, Patrice ^d   Chabre, Olivier ^a   Bosson, Jean Luc ^c  

^a HÔPITAL MICHALLON   (France)

^b GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^c LABORATOIRE TIMC IMAG   (France)

^d University Grenoble Alpes   (France)

Author keywords

Adrenal insufficiency; Critical care; Etomidate; Outcome

Indexed keywords

11BETA DEOXYCORTISOL; ALBUMIN; DOBUTAMINE; ETOMIDATE; HYDROCORTISONE; HYDROCORTISONE DERIVATIVE; NORADRENALIN; SODIUM CHLORIDE; TETRACOSACTIDE; UNCLASSIFIED DRUG;

ADRENAL INSUFFICIENCY; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ARTIFICIAL VENTILATION; BRAIN INJURY; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CORTICOTROPIN TEST; CRITICALLY ILL PATIENT; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG EFFICACY; ENDOTRACHEAL INTUBATION; FEMALE; HEMODYNAMIC MONITORING; HORMONAL REGULATION; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; MULTIPLE TRAUMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SINGLE DRUG DOSE;

ADRENAL INSUFFICIENCY; ADULT; ANESTHETICS, INTRAVENOUS; CRITICAL ILLNESS; DOUBLE-BLIND METHOD; ETOMIDATE; FEMALE; HUMANS; HYDROCORTISONE; INFUSIONS, INTRAVENOUS; INTUBATION, INTRATRACHEAL; MALE; MIDDLE AGED; TIME FACTORS;

EID: 84055161242     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31822d7938     Document Type: Article

References (45)

1. Annane D: ICU physicians should abandon the use of etomidate! Intensive Care Med 2005; 31:325-326
2. Jackson WL Jr: Should we use etomidate as an induction agent for endotracheal intubation in patients with septic shock? A critical appraisal. Chest 2005; 127:1031-1038
3. Morris C, McAllister C: Etomidate for emergency anaesthesia; mad, bad and dangerous to know? Anaesthesia 2005; 60:737-740
4. Bloomfield R, Noble DW: Etomidate, pharmacological adrenalectomy and the critically ill: A matter of vital importance. Crit Care 2006; 10:161
5. Murray H, Marik PE: Etomidate for endotracheal intubation in sepsis: Acknowledging the good while accepting the bad. Chest 2005; 127:707-709
6. Kamp R, Kress JP: Etomidate, sepsis, and adrenal function: Not as bad as we thought? Crit Care 2007; 11:145
7. Fengler BT: Should etomidate be used for rapid-sequence intubation induction in critically ill septic patients? Am J Emerg Med 2008; 26:229-232
8. Andrade FM: Is etomidate really that bad in septic patients? Intensive Care Med 2010; 36:1266-1267; author reply 1269-1270
9. Edwin SB, Walker PL: Controversies surrounding the use of etomidate for rapid sequence intubation in patients with suspected sepsis. Ann Pharmacother 2010; 44: 1307-1313
10. Gooding JM, Weng JT, Smith RA, et al: Cardiovascular and pulmonary responses following etomidate induction of anesthesia in patients with demonstrated cardiac disease. Anesth Analg 1979; 58:40-41
11. Oglesby AJ: Should etomidate be the induction agent of choice for rapid sequence intubation in the emergency department? Emerg Med J 2004; 21:655-659
12. Vinclair M, Broux C, Faure P, et al: Duration of adrenal inhibition following a single dose of etomidate in critically ill patients. Intensive Care Med 2008; 34:714-719
13. Cooper MS, Stewart PM: Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003; 348:727-734
14. Malerba G, Romano-Girard F, Cravoisy A, et al: Risk factors of relative adrenocortical deficiency in intensive care patients needing mechanical ventilation. Intensive Care Med 2005; 31:388-392
15. Lipiner-Friedman D, Sprung CL, Laterre PF, et al: Adrenal function in sepsis: The retrospective Corticus cohort study. Crit Care Med 2007; 35:1012-1018
16. den Brinker M, Hokken-Koelega AC, Hazelzet JA, et al: One single dose of etomidate negatively influences adrenocortical performance for at least 24h in children with meningococcal sepsis. Intensive Care Med 2008; 34:163-168
17. Hildreth AN, Mejia VA, Maxwell RA, et al: Adrenal suppression following a single dose of etomidate for rapid sequence induction: A prospective randomized study. J Trauma 2008; 65:573-579
18. Cuthbertson BH, Sprung CL, Annane D, et al: The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med 2009; 35: 1868-1876
19. Warner KJ, Cuschieri J, Jurkovich GJ, et al: Single-dose etomidate for rapid sequence intubation may impact outcome after severe injury. J Trauma 2009; 67:45-50
20. Jones AE, Yiannibas V, Johnson C, et al: Emergency department hypotension predicts sudden unexpected in-hospital mortality: A prospective cohort study. Chest 2006; 130: 941-946
21. Jeremitsky E, Omert L, Dunham CM, et al: Harbingers of poor outcome the day after severe brain injury: Hypothermia, hypoxia, and hypoperfusion. J Trauma 2003; 54: 312-319
22. Bollaert PE, Charpentier C, Levy B, et al: Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998; 26:645-650
23. Briegel J, Forst H, Haller M, et al: Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27:723-732
24. Annane D, Sebille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862-871
25. Oppert M, Schindler R, Husung C, et al: Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 2005; 33:2457-2464
26. Sprung CL, Annane D, Keh D, et al: Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358:111-124
27. Marik PE, Pastores SM, Annane D, et al: Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008; 36:1937-1949
28. Nicolas-Robin A, Barouk JD, Amour J, et al: Hydrocortisone supplementation enhances hemodynamic stability in brain-dead patients. Anesthesiology 2010; 112:1204-1210
29. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707-710
30. Annane D, Sebille V, Troche G, et al: A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283:1038-1045
31. Cohan P, Wang C, McArthur DL, et al: Acute secondary adrenal insufficiency after traumatic brain injury: A prospective study. Crit Care Med 2005; 33:2358-2366
32. Tanriverdi F, Senyurek H, Unluhizarci K, et al: High risk of hypopituitarism after traumatic brain injury: A prospective investigation of anterior pituitary function in the acute phase and 12 months after trauma. J Clin Endocrinol Metab 2006; 91:2105-2111
33. Prigent H, Maxime V, Annane D: Science review: Mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids. Crit Care 2004; 8:243-252
34. Schenarts CL, Burton JH, Riker RR: Adrenocortical dysfunction following etomidate induction in emergency department patients. Acad Emerg Med 2001; 8:1-7
35. Absalom A, Pledger D, Kong A: Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia 1999; 54:861-867
36. Bratton SL, Chestnut RM, Ghajar J, et al: Guidelines for the management of severe traumatic brain injury. I. Blood pressure and oxygenation. J Neurotrauma 2007; 24(Suppl 1): S7-S13
37. de Jong MF, Beishuizen A, Spijkstra JJ, et al: Relative adrenal insufficiency: An identifiable entity in nonseptic critically ill patients? Clin Endocrinol (Oxf) 2007; 66:732-739
38. Hoen S, Mazoit JX, Asehnoune K, et al: Hydrocortisone increases the sensitivity to alpha1-adrenoceptor stimulation in humans following hemorrhagic shock. Crit Care Med 2005; 33:2737-2743
39. Silverman HJ, Penaranda R, Orens JB, et al: Impaired beta-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: Association with myocardial hyporesponsiveness to catecholamines. Crit Care Med 1993; 21:31-39
40. Baird CR, Hay AW, McKeown DW, et al: Rapid sequence induction in the emergency department: Induction drug and outcome of patients admitted to the intensive care unit. Emerg Med J 2009; 26:576-579
41. Riche FC, Boutron CM, Valleur P, et al: Adrenal response in patients with septic shock of abdominal origin: Relationship to survival. Intensive Care Med 2007; 33:1761-1766
42. Ray DC, McKeown DW: Effect of induction agent on vasopressor and steroid use, and outcome in patients with septic shock. Crit Care 2007; 11:R56
43. Dmello D, Taylor S, O'Brien J, et al: Outcomes of etomidate in severe sepsis and septic shock. Chest 2010; 138:1327-1332
44. Jabre P, Combes X, Lapostolle F, et al: Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: A multicentre randomised controlled trial. Lancet 2009; 374:293-300
45. Tekwani KL, Watts HF, Sweis RT, et al: A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: A prospective, randomized study. Ann Emerg Med 2010; 56:481-489